# Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer

> **NCT00040794** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 144 (actual)

## Conditions studied

- Adenocarcinoma of the Lung
- Adenosquamous Cell Lung Cancer
- Bronchoalveolar Cell Lung Cancer
- Large Cell Lung Cancer
- Squamous Cell Lung Cancer
- Stage IIIA Non-small Cell Lung Cancer
- Stage IIIB Non-small Cell Lung Cancer

## Interventions

- **DRUG:** paclitaxel
- **DRUG:** carboplatin
- **DRUG:** gefitinib
- **RADIATION:** radiation therapy
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00040794
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** 2006-03
- **Final completion:** —
- **Target enrollment:** 144 (ACTUAL)
- **Last updated:** 2013-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00040794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00040794, "Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00040794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*